Table 4 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
What is Cyfra 21-1 quantification? | Vinmec
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
Cyfra 21-1 Cancer Antigen
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram
CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma? | SpringerLink
CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
Ultrasensitive label-free detection for lung cancer CYFRA 21-1 DNA based on ring-opening polymerization - ScienceDirect
IVD Antibody Development Services for CYFRA21-1 Marker - Creative Biolabs
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect
New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | SpringerLink
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE